CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosisFelix Fischbach, Nicolaus Kröger, Johanna Richter et al.|Med|2024Cited by 161
Anti-CD19 CAR T cells for refractory myasthenia gravisAiden Haghikia, Dimitrios Mougiakakos, Roland Schroers et al.|The Lancet Neurology|2023Cited by 147
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndromeSimon Faissner, Ralf Gold, Jeremias Motte et al.|Proceedings of the National Academy of Sciences|2024Cited by 70
CD19-Directed CAR T Cell Therapy in 4 Patients with Refractory Multiple SclerosisJohanna Richter, Nicolaus Kroeger, Felix Fischbach et al.|Blood|2024Cited by 9